Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine vs propofol combined with fentanyl for sedation during IDDS implantation in advanced cancer pain
ChiCTR1900025079Phase 4Recruiting
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- Aug 2019
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dexmedetomidine, propofol and fentanyl in cancer pain (3 arms), sponsored by Jiangsu Provincial People's Hospital. Primary endpoints: Visual analog scale pain score and Ramsay sedation score. Started Aug 2019; status: recruiting.
02
Drugs
dexmedetomidinepropofolfentanyl
03
Conditions
cancer pain
Beyond the preview
Go deeper on ChiCTR1900025079.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900025079.